RHOBTB2 antisense RNA 1 (RHOBTB2-AS1)

RHOBTB2 antisense RNA 1 (RHOBTB2-AS1) refers to an antisense long non-coding RNA (lncRNA) transcribed from the region antisense to the RHOBTB2 (Rho-related BTB domain containing protein 2) gene. This lncRNA likely does not code for a functional protein and, as of current literature and curated data, has not been characterized as a therapeutic target, receptor, enzyme, transporter, or similar druggable entity. No explicit biological role, interaction with drugs, or relevance as a clinical biomarker or therapeutic target has been established for RHOBTB2-AS1 in peer-reviewed studies or curated target databases. Most functional and disease-related information concerns the protein-coding gene RHOBTB2, which should not be conflated with RHOBTB2-AS1[1][2][3][4]. Note: - If you intended the protein-coding RHOBTB2 gene, see sources above for its known roles in cancer and neurodevelopmental disorders. - This entry is likely incorrect as a therapeutic target, as RHOBTB2-AS1 itself is not a characterized molecular target for drugs or therapy. - There is no evidence from available sources that RHOBTB2-AS1 directly participates in cellular pathways relevant to drug targeting, nor is it established as a disease gene. Summary of issues: - RHOBTB2 antisense RNA 1 refers to a non-coding RNA, not the protein-coding tumor suppressor gene RHOBTB2, which is responsible for known biological effects and disease associations. - No evidence supports RHOBTB2-AS1 as a drug target or molecular entity relevant to classic therapeutic approaches. - For information on RHOBTB2, a GTPase and tumor suppressor, refer to the provided protein-coding gene details[1][2][4].

Other names

RHOBTB2-AS1RhoBTB2 antisense non-coding RNA